Raymond James Financial Services Advisors’s Guardant Health GH Stock Holding History

Raymond James Financial Services Advisors’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$443K	Buy	+19,294	New	+$546K	﹤0.01%	2709
2022 Q1	–	Sell	-4,180	Closed	-$418K	–	3377
2021 Q4	$418K	Sell	4,180 -1,082	-21%	-$112K	﹤0.01%	2493
2021 Q3	$658K	Buy	5,262 +48	+0.9%	+$5.7K	﹤0.01%	2199
2021 Q2	$648K	Sell	5,214 -420	-7%	-$56.5K	﹤0.01%	2211
2021 Q1	$860K	Buy	5,634 +812	+17%	+$123K	﹤0.01%	1950
2020 Q4	$621K	Buy	4,822 +1,629	+51%	+$187K	﹤0.01%	2010
2020 Q3	$357K	Sell	3,193 -556	-15%	-$50.9K	﹤0.01%	2184
2020 Q2	$304K	Sell	3,749 -367	-9%	-$29.6K	﹤0.01%	2223
2020 Q1	$286K	Sell	4,116 -149	-3%	-$11.4K	﹤0.01%	1874
2019 Q4	$333K	Sell	4,265 -62	-1%	-$4.47K	﹤0.01%	2253
2019 Q3	$276K	Sell	4,327 -2,368	-35%	-$209K	﹤0.01%	2290
2019 Q2	$578K	Buy	6,695 +2,944	+78%	+$225K	﹤0.01%	1829
2019 Q1	$288K	Buy	+3,751	New	+$208K	﹤0.01%	2267

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Raymond James Financial Services Advisors's GH Position: Q3 2024 in Review

Raymond James Financial Services Advisors opened a new position in Guardant Health (GH) in Q3 2024: 19,294 shares worth $443K. The stake represents ﹤0.01% of the portfolio and ranks #2709 among its holdings. This is a return to the name: Raymond James Financial Services Advisors previously reported a position in GH as recently as Q4 2021.

Raymond James Financial Services Advisors first reported a position in GH in Q1 2019 and has held it in 13 quarters since. The position peaked at $860K in Q1 2021. 271 funds tracked by Wall St. Rank hold GH as of Q3 2024.

Raymond James Financial Services Advisors held 19,294 shares of Guardant Health worth $443K as of Q3 2024.
Guardant Health was a new Raymond James Financial Services Advisors position in Q3 2024.
Guardant Health made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2709 holding.
Raymond James Financial Services Advisors first reported a position in Guardant Health in Q1 2019 and has held it in 13 quarters since.
Raymond James Financial Services Advisors's Guardant Health position peaked at $860K in Q1 2021.
271 funds tracked by Wall St. Rank held Guardant Health as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.